EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

A Short-Course Regimen Containing Delamanid, Bedaquiline and Linezolid for the Treatment of Drug-Resistant Tuberculosis: A Retrospective Study from China

Long Jin, Xiaolei Zhang, Huailong Jiang, Qijian Li, Weinan Liu, Jiayao Wang, Zheyu Cao, Yuqin Liu

Infection and Drug Resistance · 2026-07 · Volume 19 · 1-15

DOI: 10.2147/idr.s596822 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Drug Resistance, 2026-07. Verfasst von Long Jin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine for Tuberculosis, Infectious Disease Hospital of Heilongjiang Province, Harbin, 150500, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

MDR-TBRR-TBbedaquilinedelamanidlinezolidmultidrug-resistant TBrifampicin-resistant TBtuberculosis

Autor:innen und Institutionen

  • Department of Internal Medicine for Tuberculosis, Infectious Disease Hospital of Heilongjiang Province, Harbin, 150500, People's Republic of China.

Zitieren

APA

Jin, L., Zhang, X., Jiang, H., Li, Q., Liu, W., Wang, J., Cao, Z., & Liu, Y. (2026). A Short-Course Regimen Containing Delamanid, Bedaquiline and Linezolid for the Treatment of Drug-Resistant Tuberculosis: A Retrospective Study from China. Infection and Drug Resistance, Volume 19, 1-15. https://doi.org/10.2147/idr.s596822

Vancouver

Jin L, Zhang X, Jiang H, Li Q, Liu W, Wang J, et al. A Short-Course Regimen Containing Delamanid, Bedaquiline and Linezolid for the Treatment of Drug-Resistant Tuberculosis: A Retrospective Study from China. Infection and Drug Resistance. 2026;Volume 19:1-15. doi:10.2147/idr.s596822

BibTeX
@article{Jin2026,
  author = {Jin, Long and Zhang, Xiaolei and Jiang, Huailong and Li, Qijian and Liu, Weinan and Wang, Jiayao and Cao, Zheyu and Liu, Yuqin},
  title = {A Short-Course Regimen Containing Delamanid, Bedaquiline and Linezolid for the Treatment of Drug-Resistant Tuberculosis: A Retrospective Study from China},
  journal = {Infection and Drug Resistance},
  year = {2026},
  volume = {Volume 19},
  pages = {1--15},
  doi = {10.2147/idr.s596822}
}
Kostenlos starten →